Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Ellipticine + Valproic acid |
Synonyms | |
Therapy Description | |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Ellipticine | Ellipticine produces DNA damage through intercalation into DNA, inhibition of DNA topoisomerase, and formation of ellipticine-DNA adducts, resulting in cell-cycle arrest and growth inhibition in tumor cells (PMID: 21753906, PMID: 32335141). | |||
Valproic acid | Stavzor | Depacon|Valproate Sodium|Depakene | HDAC Inhibitor 45 | Valproic acid inhibits HDAC activity, potentially resulting in decreased angiogenesis, increased tumor cell differentiation, and reduced tumor growth (PMID: 11742974, PMID: 14978230). Valproic acid is FDA-approved for use in treating seizures (FDA.gov). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|